DE2022746A1 - Blutzuckersenkende Sulfonylaminopyrimidine und Verfahren zu deren Herstellung - Google Patents

Blutzuckersenkende Sulfonylaminopyrimidine und Verfahren zu deren Herstellung

Info

Publication number
DE2022746A1
DE2022746A1 DE19702022746 DE2022746A DE2022746A1 DE 2022746 A1 DE2022746 A1 DE 2022746A1 DE 19702022746 DE19702022746 DE 19702022746 DE 2022746 A DE2022746 A DE 2022746A DE 2022746 A1 DE2022746 A1 DE 2022746A1
Authority
DE
Germany
Prior art keywords
general formula
given above
meaning given
compounds
tetrahydronaphthalene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702022746
Other languages
German (de)
English (en)
Inventor
Walter Dr Aumueller
Adolf Dr Phil Hagedorn
Ruth Dr Rer Nat Heerdt
Dr Rer Nat Schmidt Feli Helmut
Manfred Dr Rer Nat Huebner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE19702022746 priority Critical patent/DE2022746A1/de
Priority to CH664071A priority patent/CH563992A5/xx
Priority to CH359575A priority patent/CH572913A5/xx
Priority to CH359375A priority patent/CH563993A5/xx
Priority to CH359475A priority patent/CH563994A5/xx
Priority to GB03422/71A priority patent/GB1291661A/en
Priority to AT399671A priority patent/AT306728B/de
Priority to FR7116514A priority patent/FR2100641B1/fr
Priority to AT410272A priority patent/AT306737B/de
Priority to AT410372A priority patent/AT307428B/de
Priority to AT410472A priority patent/AT306738B/de
Publication of DE2022746A1 publication Critical patent/DE2022746A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19702022746 1970-05-09 1970-05-09 Blutzuckersenkende Sulfonylaminopyrimidine und Verfahren zu deren Herstellung Pending DE2022746A1 (de)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DE19702022746 DE2022746A1 (de) 1970-05-09 1970-05-09 Blutzuckersenkende Sulfonylaminopyrimidine und Verfahren zu deren Herstellung
CH664071A CH563992A5 (pl) 1970-05-09 1971-05-05
CH359575A CH572913A5 (pl) 1970-05-09 1971-05-05
CH359375A CH563993A5 (pl) 1970-05-09 1971-05-05
CH359475A CH563994A5 (pl) 1970-05-09 1971-05-05
GB03422/71A GB1291661A (en) 1970-05-09 1971-05-06 Sulphonylamino-pyrimidines
AT399671A AT306728B (de) 1970-05-09 1971-05-07 Verfahren zur Herstellung von neuen Tetrahydronaphthalinsulfonylaminopyrimidinen sowie deren Salzen
FR7116514A FR2100641B1 (pl) 1970-05-09 1971-05-07
AT410272A AT306737B (de) 1970-05-09 1971-05-07 Verfahren zur Herstellung von neuen Tetrahydronaphthalinsulfonylaminopyrimidinen sowie deren Salzen
AT410372A AT307428B (de) 1970-05-09 1971-05-07 Verfahren zur Herstellung von neuen Tetrahydronaphthalinsulfonylaminopyrimidinen sowie deren Salzen
AT410472A AT306738B (de) 1970-05-09 1971-05-07 Verfahren zur Herstellung von neuen Tetrahydronaphthalinsulfonylaminopyrimidinen sowie deren Salzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702022746 DE2022746A1 (de) 1970-05-09 1970-05-09 Blutzuckersenkende Sulfonylaminopyrimidine und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
DE2022746A1 true DE2022746A1 (de) 1971-12-02

Family

ID=5770688

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702022746 Pending DE2022746A1 (de) 1970-05-09 1970-05-09 Blutzuckersenkende Sulfonylaminopyrimidine und Verfahren zu deren Herstellung

Country Status (5)

Country Link
AT (4) AT306737B (pl)
CH (4) CH572913A5 (pl)
DE (1) DE2022746A1 (pl)
FR (1) FR2100641B1 (pl)
GB (1) GB1291661A (pl)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2125514A1 (pl) * 1971-02-17 1972-09-29 Hoechst Ag
EP0420064A2 (en) * 1989-09-25 1991-04-03 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
WO2012070015A1 (en) * 2010-11-24 2012-05-31 Stemergie Biotechnology Sa Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2152230A1 (de) * 1971-10-20 1973-04-26 Boehringer Mannheim Gmbh Blutzuckersenkende sulfonylaminopyrimidine und verfahren zu deren herstellung

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2125514A1 (pl) * 1971-02-17 1972-09-29 Hoechst Ag
EP0420064A2 (en) * 1989-09-25 1991-04-03 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
EP0420064A3 (en) * 1989-09-25 1992-02-26 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
WO2012070015A1 (en) * 2010-11-24 2012-05-31 Stemergie Biotechnology Sa Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases

Also Published As

Publication number Publication date
AT306728B (de) 1973-04-25
CH563994A5 (pl) 1975-07-15
AT306737B (de) 1973-04-25
GB1291661A (en) 1972-10-04
AT306738B (de) 1973-04-25
FR2100641B1 (pl) 1975-04-18
CH572913A5 (pl) 1976-02-27
AT307428B (de) 1973-05-25
CH563993A5 (pl) 1975-07-15
FR2100641A1 (pl) 1972-03-24
CH563992A5 (pl) 1975-07-15

Similar Documents

Publication Publication Date Title
DE2517229A1 (de) Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
CH634567A5 (de) Verfahren zur herstellung von uracilderivaten.
DE2022746A1 (de) Blutzuckersenkende Sulfonylaminopyrimidine und Verfahren zu deren Herstellung
DE1670168C3 (de) 2-Benzolsulfonamido-4-methyl-5alkyl-pyrimidine und Verfahren zu ihrer Herstellung
DE2427272C3 (de) 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum
CH513180A (de) Verfahren zur Herstellung antidiabetisch wirksamer Sulfonamide
DE946804C (de) Verfahren zur Herstellung von schwefelhaltigen Abkoemmlingen der Barbitursaeure
DE2140865A1 (de) 1-imidazolyl-methanphosphonsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE1445531C3 (de) In 5 Stellung substituierte 2 Benzol sulfonamidopynmidine und Verfahren zu deren Herstellung
AT332881B (de) Verfahren zur herstellung des neuen n-(4-(beta- (2-methoxy-5-chlor-benzamido) -athyl)-benzolsulfonyl) -n'-cyclopentylharnstoffs und seiner salze
DE1670282C3 (de) Antidiabetisch wirksame Hydrindensulfonylamino-pyrimidine sowie Verfahren zu deren Herstellung
DE2911492C2 (de) 5-Substituierte Picolinsäuren, deren Natrium-, Kalium-, Magnesium-, Calcium- und Aluminiumsalze, 5-Indanylester und Säureamide Verfahren zu deren Herstellung und antihypertonische Mittel, welche diese enthalten
DE1445505C3 (de) Im Phenylkern substituierte 2-Phenylamino-13-diazacyclopentene-(2)
DE1745780C3 (de) l-Sulfonyläthyl^-methyl-S-nitroimidazole und Verfahren zu ihrer Herstellung
DE2942643C2 (de) Thienyl(2)-carbonylphenoxyessigsäureester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT333298B (de) Verfahren zur herstellung von neuen acylaminoalkylbenzolsulfonylharnstoffen und deren salzen
AT236407B (de) Verfahren zur Herstellung von neuen Benzolsulfonyl-alkylen-semicarbaziden
DE1200824B (de) Verfahren zur Herstellung von 3, 5-Dioxo-triazolidinen
AT235848B (de) Verfahren zur Herstellung von neuen Benzolsulfonylalkylensemicarbaziden
DE2048906A1 (de) Blutzuckersenkende Sulfonylaminopyrimidine und Verfahren zu deren Herstellung
DE1901076A1 (de) Antidiabetisch wirksame Sulfonylaminopyrimidine und Verfahren zu deren Herstellung
DE1668199B2 (de) Benzolsulfonyl-3-(2-hydroxycyclohexyl)harnstoffe
DE2135805A1 (de) Blutzuckersenkende sulfonylharnstoffe und sulfonylsemicarbazide und verfahren zu deren herstellung
AT331809B (de) Verfahren zur herstellung von neuen benzolsulfonylharnstoffen
DE1493567C3 (de) Ester von alpha-Alkylthyroxinderivaten und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
OHW Rejection